Description

Tirzepatide Microdose Capsules (500mcg) 25ct | Laboratory Research Compound | Mile High Peptides LLC

Commonly Researched For:

• Ultra‑low dose GLP/GIP signaling

• Appetite and satiety microdosing models

• Metabolic sensitivity and dose‑response research

Description

Tirzepatide Microdose capsules are designed for researchers who want to study very low, highly controlled exposure to this dual GIP/GLP‑1 receptor agonist. Using a 500mcg amount per capsule allows labs to explore microdosing concepts, receptor sensitivity, and fine‑tuned dose‑response curves in a way that’s hard to achieve with larger formats.

Researchers commonly use Tirzepatide microdoses in in‑vitro models focused on appetite regulation, insulin and glucose signaling, and subtle shifts in metabolic markers. These small, repeatable amounts make it easier to design experiments that track incremental changes, layering different exposure levels over time while keeping dosing precise and consistent.

Each bottle contains 25 capsules at 500mcg per capsule for a total of 12.5mg per bottle.

Mile High Peptides LLC supplies this compound for research and educational purposes.

Product Details

• Total compound per capsule: 500mcg (0.5mg)
• 25 capsules per bottle
• Laboratory research use only
• Intended for analytical and in-vitro research applications

Important Notice

• For laboratory research and educational purposes only
• Not for human consumption
• Not for medical, cosmetic, or therapeutic use
• Not intended to diagnose, treat, cure, or prevent any disease
• Observations and research outcomes may vary based on handling, storage, environment, methodology, and study conditions
• Materials supplied are not finished consumer products

Mile High Peptides LLC supplies materials strictly for in-vitro laboratory research and analytical applications by qualified research professionals.